EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access · CC BY 4.0

Impact of thromboprophylaxis on hospital acquired thrombosis following discharge in patients admitted with COVID ‐19: Multicentre observational study in the UK

Deepa J Arachchillage iD, Indika Rajakaruna, Zain Odho iD, Mike Makris, Mike Laffan iD, CA-COVID19 Investigators

British Journal of Haematology · 2023

DOI: 10.1111/bjh.18874 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift British Journal of Haematology, 2023. Verfasst von Deepa J Arachchillage und 5 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, London, UK. Hauptthemen laut MEDLINE: COVID-19, Thrombosis, Venous Thromboembolism. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, Bayer, United Kingdom.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Post‐discharge thromboprophylaxis in patients admitted with COVID‐19 remains controversial. We aimed to determine the impact of thromboprophylaxis on hospital acquired thrombosis (HAT) in patients (≥18 years) discharged following admission for COVID‐19 in an observational study across 26 NHS Trusts in the UK (01.04.2020–31.12.2021). Overall, 8895 patients were included to the study: 971 patients were discharged with thromboprophylaxis and propensity score matched (PSM) with a desired ratio of 1:1, from patients discharged without thromboprophylaxis. Patients with heparin induced thrombocytopenia, major bleeding during admission and pregnant women were excluded. As expected from 1:1 PSM, no difference was observed in parameters between the two groups, including duration of hospital stay, except the thromboprophylaxis group had a significantly higher proportion who had received therapeutic dose anticoagulation during admission. There were no differences in the laboratory parameters especially D‐dimers between the two groups at admission or discharge. Median duration of thromboprophylaxis following discharge from hospital was 4 weeks (1–8 weeks). No difference was found in HAT in patients discharged with TP versus no TP (1.3% vs. 0.92%, p = 0.52). Increasing age and smoking significantly increased the risk of HAT. Many patients in both cohorts had raised D‐dimer at discharge but D‐dimer was not associated with increased risk of HAT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19ThrombosisVenous ThromboembolismFemaleHumansAftercareAnticoagulantsHospitalsPatient DischargeUnited Kingdom

Stichwörter der Autor:innen

COVID-19D-dimerThromboprophylaxisanticoagulantshospital acquired thrombosispropensity matching

Substanzen

Anticoagulants

Autor:innen und Institutionen

  • Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, London, UK.
  • Department of Haematology, Imperial College Healthcare NHS Trust, London, UK.
  • Department of Computer Science, University of East London, University Way, London, UK.
  • Department of Biochemistry, Royal Brompton Hospital, London, UK.
  • Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.

ORCID-Profile: Deepa J Arachchillage, Zain Odho, Mike Laffan

Förderung

  • Medical Research Council
  • Bayer, United Kingdom

Zitieren

APA

Arachchillage, D. J., Rajakaruna, I., Odho, Z., Makris, M., Laffan, M., & CA-COVID19 Investigators (2023). Impact of thromboprophylaxis on hospital acquired thrombosis following discharge in patients admitted with COVID ‐19: Multicentre observational study in the UK. British Journal of Haematology. https://doi.org/10.1111/bjh.18874

Vancouver

Arachchillage DJ, Rajakaruna I, Odho Z, Makris M, Laffan M, CA-COVID19 Investigators. Impact of thromboprophylaxis on hospital acquired thrombosis following discharge in patients admitted with COVID ‐19: Multicentre observational study in the UK. British Journal of Haematology. 2023. doi:10.1111/bjh.18874

BibTeX
@article{Arachchillage2023,
  author = {Arachchillage, Deepa J and Rajakaruna, Indika and Odho, Zain and Makris, Mike and Laffan, Mike and CA-COVID19 Investigators, CA-COVID19 Investigators},
  title = {Impact of thromboprophylaxis on hospital acquired thrombosis following discharge in patients admitted with COVID ‐19: Multicentre observational study in the UK},
  journal = {British Journal of Haematology},
  year = {2023},
  doi = {10.1111/bjh.18874}
}
Kostenlos starten →